United States Positive Expiratory Pressure Devices Market Outlook 2034: Growth Drivers and Industry Trends
The US Positive Expiratory Pressure Devices Market is supported by the growing burden of respiratory disorders and increasing use of airway clearance therapies. PEP devices are being adopted across hospitals, clinics, and home healthcare environments to support respiratory management. Rising healthcare expenditure and ongoing innovation in respiratory care technologies are further contributing to market development.
According to The Insight Partners, the Positive Expiratory Pressure Devices Market size is expected to reach US$ 2.83 Billion by 2034 from US$ 1.34 Billion in 2025. The market is estimated to record a CAGR of 8.67% from 2026 to 2034. The market is analyzed across product types, pressure types, applications, end users, and geographic regions. Product types include face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices, while pressure types include high-pressure PEP and low-pressure PEP. Applications covered include atelectasis, bronchiectasis, bronchitis, cystic fibrosis, asthma, and COPD.
Positive Expiratory Pressure Devices Market Size, Share, Trends, Analysis, and Forecast by 2034
- Market Size: The global Positive Expiratory Pressure Devices Market was valued at US$ 1.34 Billion in 2025 and is projected to reach US$ 2.83 Billion by 2034.
- Market Growth: The market is projected to expand at a CAGR of 8.67% from 2026 to 2034.
- Product Type: The market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices.
Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00015241
- Pressure Type: Key categories include high-pressure PEP and low-pressure PEP devices.
- Application: Major applications include atelectasis, bronchiectasis, bronchitis, cystic fibrosis, asthma, and COPD.
- End User: Hospitals and clinics and ambulatory surgical centers represent the principal end-user segments.
- Emerging Trends: Smart PEP devices, telehealth integration, personalized respiratory therapy, and the increasing adoption of home-based respiratory care are among the trends shaping the market.
- Market Opportunities: Product development focused on affordability, portability, patient comfort, and ease of use is expected to create opportunities for market participants.
Regional Analysis
The Positive Expiratory Pressure Devices Market is analyzed across North America, Europe, Asia-Pacific, South and Central America, and the Middle East and Africa. North America represents an important regional market due to its established healthcare infrastructure, adoption of advanced respiratory-care technologies, and increasing focus on airway-clearance therapies. The region includes the US, Canada, and Mexico. Europe is also an important market, supported by healthcare infrastructure and demand for respiratory management solutions. Asia-Pacific offers opportunities associated with expanding healthcare services, increasing awareness of respiratory disorders, and improving access to medical devices. South and Central America and the Middle East and Africa are also covered in the market assessment, with growth influenced by healthcare investment and access to respiratory-care technologies.
Positive Expiratory Pressure Devices Market Key Players
The competitive landscape comprises companies developing and supplying PEP and respiratory-care technologies. Key players identified in the market include:
- Smiths Medical
- Aptalis Pharma US, Inc.
- Koninklijke Philips N.V.
- Monaghan Medical Corporation
- D-R BURTON HEALTHCARE
- AirPhysio
- PARI GmbH
- CEGLA Medizintechnik
- WyMedical Pty Ltd
- Medica Holdings, Inc.
Companies in the market are focusing on product development, technological innovation, distribution expansion, partnerships, and improvements in device usability. For example, Monaghan Medical entered into a three-year agreement with Premier in 2023 to provide respiratory therapy medication-delivery devices and oscillatory PEP/positive airway pressure devices to Premier members, illustrating efforts to expand access through healthcare supply networks.
Competitive strategies are also centered on developing convenient and patient-friendly respiratory devices that can support home-based therapy. Innovation in smart technologies, personalized therapy, portable designs, and integration with digital healthcare platforms may further influence competition as manufacturers respond to changing respiratory-care requirements. The Insight Partners report profiles these companies while analyzing competitive strategies and innovation developments.
About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: [email protected]
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish
Comments